COMPASSION 3: Congenital Multicenter Trial of Pulmonic Valve Dysfunction Studying the

Grants and Contracts Details

StatusActive
Effective start/end date9/7/169/1/24

Funding

  • Edwards Lifesciences: $74,818.00